Finance

Lists
SUDEEPPHRM:NSE
Sudeep Pharma Ltd
1 016,30 INR
+0,81%
(+8,20) 1D
16 ოქტ, 11:23:06 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SUDEEPPHRM...
Open
1 016,00 INR
High
1 030,00 INR
Low
1 000,00 INR
Mkt. cap
114,79 მლრ.
Avg. vol.
247,24 ათ.
Volume
29,32 ათ.
Dividend
0,15%
Quarterly dividend
0,37 INR
Ex-dividend date
23 ივლ. 2026
P/E ratio
62,58
52-wk high
1 378,00 INR
52-wk low
524,05 INR
EPS
16,24 INR
No. of employees
525
Open
1 016,00 INR
High
1 030,00 INR
Low
1 000,00 INR
Mkt. cap
114,79 მლრ.
Avg. vol.
247,24 ათ.
Volume
29,32 ათ.
Dividend
0,15%
Quarterly dividend
0,37 INR
Ex-dividend date
23 ივლ. 2026
P/E ratio
62,58
52-wk high
1 378,00 INR
52-wk low
524,05 INR
EPS
16,24 INR
No. of employees
525
News stories
From web sources and news partners
About Sudeep Pharma Ltd
CEO-
Employees525
Founded1989
Headquarters-
SectorSpeciality chemicals
Last report
4 აგვ. 2026
Fiscal period
Q1 2027
3,59 INR / 3,60 INR
-0,28%miss
Revenue / Est. (INR)
1,58 მლრდ. / 1,70 მლრდ.
-6,84%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,63 მლრდ.
1,72 მლრდ.
1,82 მლრდ.
1,58 მლრდ.
Cost of goods sold
609,35 მლნ.
601,93 მლნ.
674,88 მლნ.
565,91 მლნ.
Cost of revenue
609,35 მლნ.
601,93 მლნ.
674,88 მლნ.
565,91 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
140,95 მლნ.
150,37 მლნ.
153,34 მლნ.
143,40 მლნ.
Operating expense
500,81 მლნ.
560,33 მლნ.
561,40 მლნ.
507,69 მლნ.
Total operating expenses
1,11 მლრდ.
1,16 მლრდ.
1,24 მლრდ.
1,07 მლრდ.
Operating income
516,50 მლნ.
561,10 მლნ.
587,11 მლნ.
509,10 მლნ.
Other non operating income
101,66 მლნ.
68,37 მლნ.
-224,91 მლნ.
54,45 მლნ.
EBT including unusual items
595,34 მლნ.
617,76 მლნ.
626,93 მლნ.
542,93 მლნ.
EBT excluding unusual items
595,34 მლნ.
617,76 მლნ.
616,16 მლნ.
542,93 მლნ.
Income tax expense
127,56 მლნ.
140,77 მლნ.
141,55 მლნ.
137,06 მლნ.
Effective tax rate
21,43%
22,79%
22,58%
25,24%
Other operating expenses
321,74 მლნ.
371,34 მლნ.
366,92 მლნ.
324,29 მლნ.
Net income
457,47 მლნ.
474,62 მლნ.
488,77 მლნ.
405,50 მლნ.
Net profit margin
28,12%
27,54%
26,81%
25,62%
Earnings per share
-
-
4,38
3,59
Interest and investment income
-
-
33,79 მლნ.
-
Interest expense
-22,82 მლნ.
-11,71 მლნ.
-19,39 მლნ.
-20,63 მლნ.
Net interest expenses
-22,82 მლნ.
-11,71 მლნ.
14,40 მლნ.
-20,63 მლნ.
Depreciation and amortization charges
38,11 მლნ.
38,61 მლნ.
38,84 მლნ.
40,01 მლნ.
EBITDA
556,94 მლნ.
601,54 მლნ.
621,58 მლნ.
543,57 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები